Industry footprint Studylog serves pharmaceutical, biotech, and top CROs with an emphasis on GLP-like study management, offering a scalable workflow solution that increases throughput while preserving data integrity and long-term accessibility. This positions them to target large enterprise customers and research institutions prioritizing compliance and efficiency.

Proof points Strong validation from leading entities (top-10 pharma, top biotech, major CROs, NCI program, and prestigious universities) plus award recognition demonstrates credibility and a differentiator against Excel and ELNs, creating a compelling case for pilots and enterprise licenses.

Global tech stack Utilizes cloud platforms (Google Cloud, Azure), modern data and collaboration tools (Slack, WordPress, Zoho), and integration-ready services (Apache Kafka, QuickBooks Online), enabling scalable deployment, data security, and smooth procurement to support expanding customer bases.

Expansion targets With a small team and revenue in the low-to-mid millions, there is a clear avenue to expand within biotech, pharma and CROs by offering targeted demonstrations, scalable pricing for larger teams, and expansion into academic labs seeking secure, perpetual data preservation.

Opportunity signals The platform’s unique ability to emulate complex clinical trial methods and improve predictability presents a compelling upsell to customers exploring advanced study designs, multi-site or multi-arm trials, and piggyback studies, offering upgrade paths from ELNs to Studylog.